Received: 31 October 2017
Accepted: 1 February 2018
First Online: 19 February 2018
: Jin-Yuan Shih has received speaking honoraria from AstraZeneca, Roche, Pfizer, Boehringer Ingelheim, Novartis, and Eli Lilly. Shang-Gin Wu has no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.